Tesamorelin
GH Axis / Metabolic
Visceral-fat reduction via GH-axis activation
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- GHRH receptor agonism
- Primary market use
- HIV lipodystrophy
Pharmacology
- Molecular weight (Da)
- 5135.9
- Oral bioavailability
- N/A
- Half-life
- ~26-38 min
- Route tags
- Route-dependent / verify
- Evidence level
- Approved
- Clinical status
- Approved
- Value-for-money score
- 6 / 10
Reported protocol signal
Treatment length: No longer than 60 days followed by equal time off Wait 2-3 hours after eating, and don’t eat for another 30 minutes after injection SQ: • 1 mg 5-6 days a week before bed (Tailor Made Compounding Catalog) • 1 mg daily (Dr. Seeds) • 1 mg in the morning (fasted) and 1 mg at bedtime (at least 90 minutes after last meal) (Jay Campbell) • 2 mg daily (Studies) • 200 mcg at bedtime for cognition, 5 days on, 2 days off for 20 weeks Tesamorelin is often stacked with Ipamorelin: SQ: • 1 mg tesamorelin right before bed (at least 90 mnutes after food) and 200 mcg ipamorelin in the morning (Jay Campbell)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Primary effect requires ongoing dosing but body-composition adaptation may persist partially